Filing Details

Accession Number:
0001449374-11-000083
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-11-22 10:35:45
Reporting Period:
2011-11-18
Filing Date:
2011-11-22
Accepted Time:
2011-11-22 10:35:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
764579 Cas Medical Systems Inc CASM Surgical & Medical Instruments & Apparatus (3841) 061123096
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1310306 M Thomas Patton C/O Cas Medical Systems, Inc.
44 East Industrial Road
Branford CT 06405
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-11-18 18,900 $1.80 493,019 No 4 P Direct
Common Stock Acquisiton 2011-11-21 14,426 $1.75 507,445 No 4 P Direct
Common Stock Acquisiton 2011-11-21 12,500 $1.75 32,500 No 4 P Indirect Reporting Person has dispositive power over the securities, which are held in a relative's IRA
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Indirect Reporting Person has dispositive power over the securities, which are held in a relative's IRA
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.76 to $1.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1).
  2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.59 to $1.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2).
  3. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.7448 to $1.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (3).